Global Alvimopan Market by Therapeutic Application (Opioid-Induced Constipation, Postoperative Ileus Prevention), End-User (Hospitals, Surgical Centers) - Forecast 2024-2030- Product Image

Sale

Global Alvimopan Market by Therapeutic Application (Opioid-Induced Constipation, Postoperative Ileus Prevention), End-User (Hospitals, Surgical Centers) - Forecast 2024-2030

Report
197 Pages
May 2024
Region: Global
360iResearch™
ID: 5968323

UP TO €845EUR$875USD£715GBP OFF until Dec 31^st 2024

The Alvimopan Market size was estimated at USD 6.20 billion in 2023, USD 6.51 billion in 2024, and is expected to grow at a CAGR of 5.23% to reach USD 8.87 billion by 2030.

Alvimopan is a medical compound categorized under the umbrella of peripherally acting μ-opioid receptor antagonists. Alvimopan is specifically designed to counteract the side effects of opioids on the bowel, thus aiding in the management of postoperative ileus, a condition where the bowel becomes temporarily paralyzed after abdominal surgery, inhibiting normal bowel functions. The global rise in surgical interventions, especially abdominal surgeries, directly correlates with the increasing demand for postoperative care solutions such as Alvimopan. Growing awareness and management strategies for opioid-induced complications further elevate the need for effective medications such as Alvimopan.

Improved healthcare facilities and an emphasis on reducing hospital stays and healthcare costs propel the adoption of Alvimopan in clinical settings. However, strict regulations and long approval processes may delay market access for Alvimopan. Alvimopan carries the risk of side effects, which may create challenges for adoption among healthcare providers and patients. Moreover, developing healthcare infrastructure and increasing surgical procedures in emerging economies present significant growth opportunities. Collaborating with healthcare facilities and insurers to highlight the cost-effectiveness of using Alvimopan may create growth potential in the market.

Regional Insights

In the Americas region, the U.S. and Canada are at the forefront in the Alvimopan market, largely due to FDA approval and its inclusion in postoperative care protocols in numerous hospitals. High healthcare spending, widespread availability of advanced medical facilities, and ongoing research contribute to its substantial use in the region. Alvimopan's adoption in the European Union varies by country, depending on national healthcare systems' policies, reimbursement practices, and the extent of awareness about postoperative care innovations. The awareness and use of Alvimopan are gradually growing, particularly in Gulf Cooperation Council (GCC) countries with robust healthcare systems.

In the APAC region, the demand for Alvimopan in China is growing, driven by increasing surgical procedures and an expanding healthcare sector. Recent patents and research have stirred interest in Alvimopan, especially for its potential benefits in enhancing postoperative recovery in the elderly population, which is significant in Japan. The market for Alvimopan in India is nascent, given the rising healthcare infrastructure and increasing awareness about postoperative care.

Market Trends by Segment

Therapeutic Application: Diverse scope of applications for easing opioid-Induced constipation
End-User: Increasing preference for alvimopan in surgical centers for treating postoperative ileus

Industry Insights

Market Dynamics
Market Disruption Analysis
Porter’s Five Forces Analysis
Value Chain & Critical Path Analysis
Pricing Analysis
Technology Analysis
Patent Analysis
Trade Analysis
Regulatory Framework Analysis
FPNV Positioning Matrix
Market Share Analysis
Strategy Analysis and Recommendations

Recent Developments

Hikma Pharmaceuticals Launches Alvimopan Capsules for Enhanced Gastrointestinal Recovery in the US

Hikma Pharmaceuticals PLC, introduced Alvimopan Capsules to the American market. This medication is designed to expedite gastrointestinal recovery following surgeries, including those involving partial bowel resections with primary anastomosis. Hikma's extensive portfolio in the US encompasses a wide array of non-injectable products, bolstered by its prowess in complex technologies such as nasal sprays - a domain where it stands out as a major supplier.

Key Company Profiles

The report delves into recent significant developments in the Alvimopan Market, highlighting leading vendors and their innovative profiles. These include Adolor Corporation, Adooq Bioscience LLC, Hikma Pharmaceuticals PLC, Manus Aktteva Biopharma LLP, Merck & Co., Inc., and Teva Pharmaceutical Industries Ltd.

This research report offers invaluable insights into various crucial aspects of the Alvimopan Market:

Market Penetration: This section thoroughly overviews the current market landscape, incorporating detailed data from key industry players.
Market Development: The report examines potential growth prospects in emerging markets and assesses expansion opportunities in mature segments.
Market Diversification: This includes detailed information on recent product launches, untapped geographic regions, recent industry developments, and strategic investments.
Competitive Assessment & Intelligence: An in-depth analysis of the competitive landscape is conducted, covering market share, strategic approaches, product range, certifications, regulatory approvals, patent analysis, technology developments, and advancements in the manufacturing capabilities of leading market players.
Product Development & Innovation: This section offers insights into upcoming technologies, research and development efforts, and notable advancements in product innovation.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

What is the current market size and projected growth?
Which products, segments, applications, and regions offer promising investment opportunities?
What are the prevailing technology trends and regulatory frameworks?
What is the market share and positioning of the leading vendors?
What revenue sources and strategic opportunities do vendors in the market consider when deciding to enter or exit?

1. Preface

1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders

2. Research Methodology

2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary4. Market Overview

5. Market Insights

5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rise in surgical interventions including abdominal surgeries
5.1.1.2. Growing awareness and management strategies for opioid-induced complications
5.1.1.3. Improved healthcare facilities worldwide
5.1.2. Restraints
5.1.2.1. Strict regulations and long approval processes
5.1.3. Opportunities
5.1.3.1. R&D initiatives for exploring therapeutic applications of alvimopan
5.1.3.2. Increasing investments in public and private healthcare infrastructure
5.1.4. Challenges
5.1.4.1. Risk of associated side effects of alvimopan
5.2. Market Segmentation Analysis
5.2.1. Therapeutic Application: Diverse scope of applications for easing opioid-Induced constipation
5.2.2. End-User: Increasing preference for alvimopan in surgical centers for treating postoperative ileus
5.3. Market Disruption Analysis
5.4. Porter’s Five Forces Analysis
5.4.1. Threat of New Entrants
5.4.2. Threat of Substitutes
5.4.3. Bargaining Power of Customers
5.4.4. Bargaining Power of Suppliers
5.4.5. Industry Rivalry
5.5. Value Chain & Critical Path Analysis
5.6. Pricing Analysis
5.7. Technology Analysis
5.8. Patent Analysis
5.9. Trade Analysis
5.10. Regulatory Framework Analysis

6. Alvimopan Market, by Therapeutic Application

6.1. Introduction
6.2. Opioid-Induced Constipation
6.3. Postoperative Ileus Prevention

7. Alvimopan Market, by End-User

7.1. Introduction
7.2. Hospitals
7.3. Surgical Centers

8. Americas Alvimopan Market

8.1. Introduction
8.2. Argentina
8.3. Brazil
8.4. Canada
8.5. Mexico
8.6. United States

9. Asia-Pacific Alvimopan Market

9.1. Introduction
9.2. Australia
9.3. China
9.4. India
9.5. Indonesia
9.6. Japan
9.7. Malaysia
9.8. Philippines
9.9. Singapore
9.10. South Korea
9.11. Taiwan
9.12. Thailand
9.13. Vietnam

10. Europe, Middle East & Africa Alvimopan Market

10.1. Introduction
10.2. Denmark
10.3. Egypt
10.4. Finland
10.5. France
10.6. Germany
10.7. Israel
10.8. Italy
10.9. Netherlands
10.10. Nigeria
10.11. Norway
10.12. Poland
10.13. Qatar
10.14. Russia
10.15. Saudi Arabia
10.16. South Africa
10.17. Spain
10.18. Sweden
10.19. Switzerland
10.20. Turkey
10.21. United Arab Emirates
10.22. United Kingdom

11. Competitive Landscape

11.1. Market Share Analysis, 2023
11.2. FPNV Positioning Matrix, 2023
11.3. Competitive Scenario Analysis
11.3.1. Hikma Pharmaceuticals Launches Alvimopan Capsules for Enhanced Gastrointestinal Recovery in the US
11.4. Strategy Analysis & Recommendation

12. Competitive Portfolio

12.1. Key Company Profiles
12.2. Key Product Portfolio

List of Figures

FIGURE 1. ALVIMOPAN MARKET RESEARCH PROCESS
FIGURE 2. ALVIMOPAN MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL ALVIMOPAN MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL ALVIMOPAN MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. GLOBAL ALVIMOPAN MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. ALVIMOPAN MARKET DYNAMICS
FIGURE 7. GLOBAL ALVIMOPAN MARKET SIZE, BY THERAPEUTIC APPLICATION, 2023 VS 2030 (%)
FIGURE 8. GLOBAL ALVIMOPAN MARKET SIZE, BY THERAPEUTIC APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL ALVIMOPAN MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
FIGURE 10. GLOBAL ALVIMOPAN MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. AMERICAS ALVIMOPAN MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 12. AMERICAS ALVIMOPAN MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. UNITED STATES ALVIMOPAN MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 14. UNITED STATES ALVIMOPAN MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. ASIA-PACIFIC ALVIMOPAN MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 16. ASIA-PACIFIC ALVIMOPAN MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. EUROPE, MIDDLE EAST & AFRICA ALVIMOPAN MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA ALVIMOPAN MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. ALVIMOPAN MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 20. ALVIMOPAN MARKET, FPNV POSITIONING MATRIX, 2023

List of Tables

TABLE 1. ALVIMOPAN MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL ALVIMOPAN MARKET SIZE, 2018-2023 (USD MILLION)
TABLE 4. GLOBAL ALVIMOPAN MARKET SIZE, 2024-2030 (USD MILLION)
TABLE 5. GLOBAL ALVIMOPAN MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
TABLE 6. GLOBAL ALVIMOPAN MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
TABLE 7. GLOBAL ALVIMOPAN MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2023 (USD MILLION)
TABLE 8. GLOBAL ALVIMOPAN MARKET SIZE, BY THERAPEUTIC APPLICATION, 2024-2030 (USD MILLION)
TABLE 9. GLOBAL ALVIMOPAN MARKET SIZE, BY OPIOID-INDUCED CONSTIPATION, BY REGION, 2018-2023 (USD MILLION)
TABLE 10. GLOBAL ALVIMOPAN MARKET SIZE, BY OPIOID-INDUCED CONSTIPATION, BY REGION, 2024-2030 (USD MILLION)
TABLE 11. GLOBAL ALVIMOPAN MARKET SIZE, BY POSTOPERATIVE ILEUS PREVENTION, BY REGION, 2018-2023 (USD MILLION)
TABLE 12. GLOBAL ALVIMOPAN MARKET SIZE, BY POSTOPERATIVE ILEUS PREVENTION, BY REGION, 2024-2030 (USD MILLION)
TABLE 13. GLOBAL ALVIMOPAN MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 14. GLOBAL ALVIMOPAN MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 15. GLOBAL ALVIMOPAN MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2023 (USD MILLION)
TABLE 16. GLOBAL ALVIMOPAN MARKET SIZE, BY HOSPITALS, BY REGION, 2024-2030 (USD MILLION)
TABLE 17. GLOBAL ALVIMOPAN MARKET SIZE, BY SURGICAL CENTERS, BY REGION, 2018-2023 (USD MILLION)
TABLE 18. GLOBAL ALVIMOPAN MARKET SIZE, BY SURGICAL CENTERS, BY REGION, 2024-2030 (USD MILLION)
TABLE 19. AMERICAS ALVIMOPAN MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2023 (USD MILLION)
TABLE 20. AMERICAS ALVIMOPAN MARKET SIZE, BY THERAPEUTIC APPLICATION, 2024-2030 (USD MILLION)
TABLE 21. AMERICAS ALVIMOPAN MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 22. AMERICAS ALVIMOPAN MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 23. AMERICAS ALVIMOPAN MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 24. AMERICAS ALVIMOPAN MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 25. ARGENTINA ALVIMOPAN MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2023 (USD MILLION)
TABLE 26. ARGENTINA ALVIMOPAN MARKET SIZE, BY THERAPEUTIC APPLICATION, 2024-2030 (USD MILLION)
TABLE 27. ARGENTINA ALVIMOPAN MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 28. ARGENTINA ALVIMOPAN MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 29. BRAZIL ALVIMOPAN MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2023 (USD MILLION)
TABLE 30. BRAZIL ALVIMOPAN MARKET SIZE, BY THERAPEUTIC APPLICATION, 2024-2030 (USD MILLION)
TABLE 31. BRAZIL ALVIMOPAN MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 32. BRAZIL ALVIMOPAN MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 33. CANADA ALVIMOPAN MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2023 (USD MILLION)
TABLE 34. CANADA ALVIMOPAN MARKET SIZE, BY THERAPEUTIC APPLICATION, 2024-2030 (USD MILLION)
TABLE 35. CANADA ALVIMOPAN MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 36. CANADA ALVIMOPAN MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 37. MEXICO ALVIMOPAN MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2023 (USD MILLION)
TABLE 38. MEXICO ALVIMOPAN MARKET SIZE, BY THERAPEUTIC APPLICATION, 2024-2030 (USD MILLION)
TABLE 39. MEXICO ALVIMOPAN MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 40. MEXICO ALVIMOPAN MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 41. UNITED STATES ALVIMOPAN MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2023 (USD MILLION)
TABLE 42. UNITED STATES ALVIMOPAN MARKET SIZE, BY THERAPEUTIC APPLICATION, 2024-2030 (USD MILLION)
TABLE 43. UNITED STATES ALVIMOPAN MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 44. UNITED STATES ALVIMOPAN MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 45. UNITED STATES ALVIMOPAN MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
TABLE 46. UNITED STATES ALVIMOPAN MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
TABLE 47. ASIA-PACIFIC ALVIMOPAN MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2023 (USD MILLION)
TABLE 48. ASIA-PACIFIC ALVIMOPAN MARKET SIZE, BY THERAPEUTIC APPLICATION, 2024-2030 (USD MILLION)
TABLE 49. ASIA-PACIFIC ALVIMOPAN MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 50. ASIA-PACIFIC ALVIMOPAN MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 51. ASIA-PACIFIC ALVIMOPAN MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 52. ASIA-PACIFIC ALVIMOPAN MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 53. AUSTRALIA ALVIMOPAN MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2023 (USD MILLION)
TABLE 54. AUSTRALIA ALVIMOPAN MARKET SIZE, BY THERAPEUTIC APPLICATION, 2024-2030 (USD MILLION)
TABLE 55. AUSTRALIA ALVIMOPAN MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 56. AUSTRALIA ALVIMOPAN MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 57. CHINA ALVIMOPAN MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2023 (USD MILLION)
TABLE 58. CHINA ALVIMOPAN MARKET SIZE, BY THERAPEUTIC APPLICATION, 2024-2030 (USD MILLION)
TABLE 59. CHINA ALVIMOPAN MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 60. CHINA ALVIMOPAN MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 61. INDIA ALVIMOPAN MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2023 (USD MILLION)
TABLE 62. INDIA ALVIMOPAN MARKET SIZE, BY THERAPEUTIC APPLICATION, 2024-2030 (USD MILLION)
TABLE 63. INDIA ALVIMOPAN MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 64. INDIA ALVIMOPAN MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 65. INDONESIA ALVIMOPAN MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2023 (USD MILLION)
TABLE 66. INDONESIA ALVIMOPAN MARKET SIZE, BY THERAPEUTIC APPLICATION, 2024-2030 (USD MILLION)
TABLE 67. INDONESIA ALVIMOPAN MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 68. INDONESIA ALVIMOPAN MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 69. JAPAN ALVIMOPAN MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2023 (USD MILLION)
TABLE 70. JAPAN ALVIMOPAN MARKET SIZE, BY THERAPEUTIC APPLICATION, 2024-2030 (USD MILLION)
TABLE 71. JAPAN ALVIMOPAN MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 72. JAPAN ALVIMOPAN MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 73. MALAYSIA ALVIMOPAN MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2023 (USD MILLION)
TABLE 74. MALAYSIA ALVIMOPAN MARKET SIZE, BY THERAPEUTIC APPLICATION, 2024-2030 (USD MILLION)
TABLE 75. MALAYSIA ALVIMOPAN MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 76. MALAYSIA ALVIMOPAN MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 77. PHILIPPINES ALVIMOPAN MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2023 (USD MILLION)
TABLE 78. PHILIPPINES ALVIMOPAN MARKET SIZE, BY THERAPEUTIC APPLICATION, 2024-2030 (USD MILLION)
TABLE 79. PHILIPPINES ALVIMOPAN MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 80. PHILIPPINES ALVIMOPAN MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 81. SINGAPORE ALVIMOPAN MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2023 (USD MILLION)
TABLE 82. SINGAPORE ALVIMOPAN MARKET SIZE, BY THERAPEUTIC APPLICATION, 2024-2030 (USD MILLION)
TABLE 83. SINGAPORE ALVIMOPAN MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 84. SINGAPORE ALVIMOPAN MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 85. SOUTH KOREA ALVIMOPAN MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2023 (USD MILLION)
TABLE 86. SOUTH KOREA ALVIMOPAN MARKET SIZE, BY THERAPEUTIC APPLICATION, 2024-2030 (USD MILLION)
TABLE 87. SOUTH KOREA ALVIMOPAN MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 88. SOUTH KOREA ALVIMOPAN MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 89. TAIWAN ALVIMOPAN MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2023 (USD MILLION)
TABLE 90. TAIWAN ALVIMOPAN MARKET SIZE, BY THERAPEUTIC APPLICATION, 2024-2030 (USD MILLION)
TABLE 91. TAIWAN ALVIMOPAN MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 92. TAIWAN ALVIMOPAN MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 93. THAILAND ALVIMOPAN MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2023 (USD MILLION)
TABLE 94. THAILAND ALVIMOPAN MARKET SIZE, BY THERAPEUTIC APPLICATION, 2024-2030 (USD MILLION)
TABLE 95. THAILAND ALVIMOPAN MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 96. THAILAND ALVIMOPAN MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 97. VIETNAM ALVIMOPAN MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2023 (USD MILLION)
TABLE 98. VIETNAM ALVIMOPAN MARKET SIZE, BY THERAPEUTIC APPLICATION, 2024-2030 (USD MILLION)
TABLE 99. VIETNAM ALVIMOPAN MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 100. VIETNAM ALVIMOPAN MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 101. EUROPE, MIDDLE EAST & AFRICA ALVIMOPAN MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2023 (USD MILLION)
TABLE 102. EUROPE, MIDDLE EAST & AFRICA ALVIMOPAN MARKET SIZE, BY THERAPEUTIC APPLICATION, 2024-2030 (USD MILLION)
TABLE 103. EUROPE, MIDDLE EAST & AFRICA ALVIMOPAN MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 104. EUROPE, MIDDLE EAST & AFRICA ALVIMOPAN MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 105. EUROPE, MIDDLE EAST & AFRICA ALVIMOPAN MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 106. EUROPE, MIDDLE EAST & AFRICA ALVIMOPAN MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 107. DENMARK ALVIMOPAN MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2023 (USD MILLION)
TABLE 108. DENMARK ALVIMOPAN MARKET SIZE, BY THERAPEUTIC APPLICATION, 2024-2030 (USD MILLION)
TABLE 109. DENMARK ALVIMOPAN MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 110. DENMARK ALVIMOPAN MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 111. EGYPT ALVIMOPAN MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2023 (USD MILLION)
TABLE 112. EGYPT ALVIMOPAN MARKET SIZE, BY THERAPEUTIC APPLICATION, 2024-2030 (USD MILLION)
TABLE 113. EGYPT ALVIMOPAN MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 114. EGYPT ALVIMOPAN MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 115. FINLAND ALVIMOPAN MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2023 (USD MILLION)
TABLE 116. FINLAND ALVIMOPAN MARKET SIZE, BY THERAPEUTIC APPLICATION, 2024-2030 (USD MILLION)
TABLE 117. FINLAND ALVIMOPAN MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 118. FINLAND ALVIMOPAN MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 119. FRANCE ALVIMOPAN MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2023 (USD MILLION)
TABLE 120. FRANCE ALVIMOPAN MARKET SIZE, BY THERAPEUTIC APPLICATION, 2024-2030 (USD MILLION)
TABLE 121. FRANCE ALVIMOPAN MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 122. FRANCE ALVIMOPAN MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 123. GERMANY ALVIMOPAN MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2023 (USD MILLION)
TABLE 124. GERMANY ALVIMOPAN MARKET SIZE, BY THERAPEUTIC APPLICATION, 2024-2030 (USD MILLION)
TABLE 125. GERMANY ALVIMOPAN MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 126. GERMANY ALVIMOPAN MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 127. ISRAEL ALVIMOPAN MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2023 (USD MILLION)
TABLE 128. ISRAEL ALVIMOPAN MARKET SIZE, BY THERAPEUTIC APPLICATION, 2024-2030 (USD MILLION)
TABLE 129. ISRAEL ALVIMOPAN MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 130. ISRAEL ALVIMOPAN MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 131. ITALY ALVIMOPAN MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2023 (USD MILLION)
TABLE 132. ITALY ALVIMOPAN MARKET SIZE, BY THERAPEUTIC APPLICATION, 2024-2030 (USD MILLION)
TABLE 133. ITALY ALVIMOPAN MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 134. ITALY ALVIMOPAN MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 135. NETHERLANDS ALVIMOPAN MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2023 (USD MILLION)
TABLE 136. NETHERLANDS ALVIMOPAN MARKET SIZE, BY THERAPEUTIC APPLICATION, 2024-2030 (USD MILLION)
TABLE 137. NETHERLANDS ALVIMOPAN MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 138. NETHERLANDS ALVIMOPAN MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 139. NIGERIA ALVIMOPAN MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2023 (USD MILLION)
TABLE 140. NIGERIA ALVIMOPAN MARKET SIZE, BY THERAPEUTIC APPLICATION, 2024-2030 (USD MILLION)
TABLE 141. NIGERIA ALVIMOPAN MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 142. NIGERIA ALVIMOPAN MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 143. NORWAY ALVIMOPAN MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2023 (USD MILLION)
TABLE 144. NORWAY ALVIMOPAN MARKET SIZE, BY THERAPEUTIC APPLICATION, 2024-2030 (USD MILLION)
TABLE 145. NORWAY ALVIMOPAN MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 146. NORWAY ALVIMOPAN MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 147. POLAND ALVIMOPAN MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2023 (USD MILLION)
TABLE 148. POLAND ALVIMOPAN MARKET SIZE, BY THERAPEUTIC APPLICATION, 2024-2030 (USD MILLION)
TABLE 149. POLAND ALVIMOPAN MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 150. POLAND ALVIMOPAN MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 151. QATAR ALVIMOPAN MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2023 (USD MILLION)
TABLE 152. QATAR ALVIMOPAN MARKET SIZE, BY THERAPEUTIC APPLICATION, 2024-2030 (USD MILLION)
TABLE 153. QATAR ALVIMOPAN MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 154. QATAR ALVIMOPAN MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 155. RUSSIA ALVIMOPAN MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2023 (USD MILLION)
TABLE 156. RUSSIA ALVIMOPAN MARKET SIZE, BY THERAPEUTIC APPLICATION, 2024-2030 (USD MILLION)
TABLE 157. RUSSIA ALVIMOPAN MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 158. RUSSIA ALVIMOPAN MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 159. SAUDI ARABIA ALVIMOPAN MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2023 (USD MILLION)
TABLE 160. SAUDI ARABIA ALVIMOPAN MARKET SIZE, BY THERAPEUTIC APPLICATION, 2024-2030 (USD MILLION)
TABLE 161. SAUDI ARABIA ALVIMOPAN MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 162. SAUDI ARABIA ALVIMOPAN MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 163. SOUTH AFRICA ALVIMOPAN MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2023 (USD MILLION)
TABLE 164. SOUTH AFRICA ALVIMOPAN MARKET SIZE, BY THERAPEUTIC APPLICATION, 2024-2030 (USD MILLION)
TABLE 165. SOUTH AFRICA ALVIMOPAN MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 166. SOUTH AFRICA ALVIMOPAN MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 167. SPAIN ALVIMOPAN MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2023 (USD MILLION)
TABLE 168. SPAIN ALVIMOPAN MARKET SIZE, BY THERAPEUTIC APPLICATION, 2024-2030 (USD MILLION)
TABLE 169. SPAIN ALVIMOPAN MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 170. SPAIN ALVIMOPAN MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 171. SWEDEN ALVIMOPAN MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2023 (USD MILLION)
TABLE 172. SWEDEN ALVIMOPAN MARKET SIZE, BY THERAPEUTIC APPLICATION, 2024-2030 (USD MILLION)
TABLE 173. SWEDEN ALVIMOPAN MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 174. SWEDEN ALVIMOPAN MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 175. SWITZERLAND ALVIMOPAN MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2023 (USD MILLION)
TABLE 176. SWITZERLAND ALVIMOPAN MARKET SIZE, BY THERAPEUTIC APPLICATION, 2024-2030 (USD MILLION)
TABLE 177. SWITZERLAND ALVIMOPAN MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 178. SWITZERLAND ALVIMOPAN MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 179. TURKEY ALVIMOPAN MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2023 (USD MILLION)
TABLE 180. TURKEY ALVIMOPAN MARKET SIZE, BY THERAPEUTIC APPLICATION, 2024-2030 (USD MILLION)
TABLE 181. TURKEY ALVIMOPAN MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 182. TURKEY ALVIMOPAN MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 183. UNITED ARAB EMIRATES ALVIMOPAN MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2023 (USD MILLION)
TABLE 184. UNITED ARAB EMIRATES ALVIMOPAN MARKET SIZE, BY THERAPEUTIC APPLICATION, 2024-2030 (USD MILLION)
TABLE 185. UNITED ARAB EMIRATES ALVIMOPAN MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 186. UNITED ARAB EMIRATES ALVIMOPAN MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 187. UNITED KINGDOM ALVIMOPAN MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2023 (USD MILLION)
TABLE 188. UNITED KINGDOM ALVIMOPAN MARKET SIZE, BY THERAPEUTIC APPLICATION, 2024-2030 (USD MILLION)
TABLE 189. UNITED KINGDOM ALVIMOPAN MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 190. UNITED KINGDOM ALVIMOPAN MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 191. ALVIMOPAN MARKET SHARE, BY KEY PLAYER, 2023
TABLE 192. ALVIMOPAN MARKET, FPNV POSITIONING MATRIX, 2023

Companies Mentioned

Adolor Corporation
Adooq Bioscience LLC
Hikma Pharmaceuticals PLC
Manus Aktteva Biopharma LLP
Merck & Co., Inc.
Teva Pharmaceutical Industries Ltd.

Methodology

LOADING...

Table Information

Report Attribute	Details
No. of Pages	197
Published	May 2024
Forecast Period	2024 - 2030
Estimated Market Value ( USD ) in 2024	$ 6.51 Billion
Forecasted Market Value ( USD ) by 2030	$ 8.87 Billion
Compound Annual Growth Rate	5.2%
Regions Covered	Global
No. of Companies Mentioned	6

PURCHASE OPTIONS

Single User License Online Access - 1 Year

Single User License PDF, Excel And Online Access - 1 Year

1 - 5 User License PDF, Excel And Online Access - 1 Year

Site License PDF, Excel And Online Access - 1 Year

Enterprise License PDF, Excel And Online Access - 1 Month

need a quote ?

License	Format	Properties	Price
SINGLE USER LICENSE Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a single user license, allowing one user access to the product.	€3258EUR$3,374USD£2,759GBP €3620EUR$3,749USD£3,065GBP
SINGLE USER LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a single user license, allowing one user access to the product.	€4127EUR$4,274USD£3,494GBP €4585EUR$4,749USD£3,883GBP
1 - 5 USER LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a 1-5 user license, allowing up to five users have access to the product.	€4996EUR$5,174USD£4,230GBP €5551EUR$5,749USD£4,700GBP
SITE LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a site license, allowing all users within a given geographical location of your organization access to the product.	€5865EUR$6,074USD£4,966GBP €6516EUR$6,749USD£5,518GBP
ENTERPRISE LICENSE PDF, Excel and Online Access - 1 Month	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one month.	This is an enterprise license, allowing all employees within your organization access to the product.	€7602EUR$7,874USD£6,438GBP €8447EUR$8,749USD£7,153GBP

Regional Insights

Market Trends by Segment

Industry Insights

Recent Developments

Hikma Pharmaceuticals Launches Alvimopan Capsules for Enhanced Gastrointestinal Recovery in the US

Key Company Profiles

This research report offers invaluable insights into various crucial aspects of the Alvimopan Market:

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

Table of Contents

Companies Mentioned

Methodology

Table Information

Related Topics

Related Reports

Alvimopan (CAS 156053-89-3) Global Market Research Report 2024

Global Chronic Idiopathic Constipation Therapeutic Market by Drug Class (Bulk-Forming Agents, Emollients, Laxatives), Route of Administration (Oral, Parenteral), Distribution Channel - Forecast 2024-2030

Global Gastrointestinal Diseases Therapeutics Market by Distribution Channel (Hospital Pharmacies, Online Pharmacies, Retail Pharmacies), Route of Administration (Intravenous, Oral), Application - Forecast 2024-2030

Global Glucagon-Like Peptide 1 (GLP-1) Agonist market (2024 Edition): Analysis by Type, End-Use (Type 2 Diabetes, NASH, Obesity), By Distribution Channel, By Route of Administration, By Region, By Country: Market Insights and Forecast (2020-2030)

Global Ceftriaxone Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2023 to 2031

About the Alvimopan Market